ESTIMATED
05/02/2024
05/02/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $0.69 | $0.69 | $0.69 |
Q2 2024 | 5 | $0.78 | $0.99 | $0.88 |
Q3 2024 | 1 | $1.05 | $1.05 | $1.05 |
Q4 2024 | 1 | $1.12 | $1.12 | $1.12 |
Q1 2025 | 2 | $0.84 | $0.84 | $0.84 |
Q2 2025 | 2 | $1.09 | $1.09 | $1.09 |
Q3 2025 | 2 | $1.23 | $1.23 | $1.23 |
Q4 2025 | 2 | $1.32 | $1.32 | $1.32 |
Bausch Health Companies Inc. last posted its earnings results on Thursday, May 2nd, 2024. The company reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.75 by $0.16. The company had revenue of 2.14 B for the quarter and had revenue of 8.76 B for the year. Bausch Health Companies Inc. has generated $-2 earnings per share over the last year ($-1.62 diluted earnings per share) and currently has a price-to-earnings ratio of -126.7. Bausch Health Companies Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/02/2024 | Q1 2024 | $0.75 | -$0.17 | -0.92 | $2.19 B | $2.14 B | 02/22/2024 | Q4 2023 | $1.02 | $1.08 | 0.06 | $2.33 B | $2.41 B | 11/02/2023 | Q3 2023 | $0.92 | -$1.03 | -1.95 | $2.24 B | 08/03/2023 | Q2 2023 | $0.75 | $0.07 | -0.68 | $2.17 B | 05/04/2023 | Q1 2023 | $0.75 | -$0.58 | -1.33 | $1.97 B | $1.94 B | 02/23/2023 | Q4 2022 | $0.92 | -$1.13 | -2.05 | $2.14 B | $2.19 B | 11/03/2022 | Q3 2022 | $0.92 | $1.10 | 0.18 | $2.05 B | 08/09/2022 | Q2 2022 | $0.89 | -$0.38 | -1.27 | $1.97 B | 05/10/2022 | Q1 2022 | $1.03 | -$0.18 | -1.21 | $1.92 B | 02/23/2022 | Q4 2021 | $1.08 | $0.24 | -0.84 | $2.19 B | $2.20 B | 11/02/2021 | Q3 2021 | $1.07 | $0.66 | -0.41 | $2.12 B | $2.11 B | 08/03/2021 | Q2 2021 | $0.97 | -$1.66 | -2.63 | $2.11 B | $2.10 B | 05/04/2021 | Q1 2021 | $0.94 | -$1.71 | -2.65 | $2.03 B | 02/24/2021 | Q4 2020 | $1.11 | -$0.43 | -1.54 | $2.17 B | $2.21 B | 11/03/2020 | Q3 2020 | $1.02 | $0.27 | -0.75 | $2.01 B | $2.14 B | 08/06/2020 | Q2 2020 | $0.66 | -$0.92 | -1.58 | $1.78 B | $1.66 B | 05/07/2020 | Q1 2020 | $0.90 | -$0.43 | -1.33 | $2.01 B | 02/19/2020 | Q4 2019 | $1.15 | -$4.30 | -5.45 | $2.23 B | $2.22 B | 11/04/2019 | Q3 2019 | $1.06 | -$0.14 | -1.2 | $2.15 B | $2.21 B | 08/06/2019 | Q2 2019 | $1.06 | -$0.49 | -1.55 | $2.18 B | $2.15 B |
---|
A. Bausch Health Companies Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates.
A. The conference call for Bausch Health Companies Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Bausch Health Companies Inc.'s latest earnings report can be read online.
A. Bausch Health Companies Inc. (NYSE:BHC) has a recorded annual revenue of $8.76 B.
A. Bausch Health Companies Inc. (NYSE:BHC) has a recorded net income of $8.76 B. Bausch Health Companies Inc. has generated $-1.62 earnings per share over the last four quarters.
A. Bausch Health Companies Inc. (NYSE:BHC) has a price-to-earnings ratio of -126.7 and price/earnings-to-growth ratio is -201.68.